Cargando…
Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
OBJECTIVES: The optimal treatment strategy for metastatic non‐clear cell renal cell carcinoma (mNCCRCC) is still elusive and mainly extrapolated from evidence available for metastatic clear cell renal cell carcinoma. The aim of the study was therefore to investigate the survival outcomes and prognos...
Autores principales: | Kim, Jung Kwon, Kim, Sung Han, Song, Mi Kyung, Joo, Jungnam, Seo, Seong Il, Kwak, Cheol, Jeong, Chang Wook, Song, Cheryn, Hwang, Eu Chang, Seo, Ill Young, Lee, Hakmin, Hong, Sung‐Hoo, Park, Jae Young, Chung, Jinsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601573/ https://www.ncbi.nlm.nih.gov/pubmed/31070307 http://dx.doi.org/10.1002/cam4.2222 |
Ejemplares similares
-
Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry
por: Kim, Jung Kwon, et al.
Publicado: (2019) -
Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium model
por: Shin, Dongrul, et al.
Publicado: (2021) -
Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
por: Park, Jae Young, et al.
Publicado: (2020) -
The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2020) -
The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)